Kristel Van Laethem

Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

Annemarie M. J. Wensing, David van de Vijver, Gioacchino Angarano et al. · The Journal of Infectious Diseases · 2005 · 420 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

L. Marije Hofstra, Nicolas Sauvageot, Jan Albert et al. · Clinical Infectious Diseases · 2015 · 160 citations · Full text

Public Health, Infectious Disease Control, Pharmacology +17

A Genotypic Drug Resistance Interpretation Algorithm that Significantly Predicts Therapy Response in HIV-1-Infected Patients

Kristel Van Laethem, Andrea De Luca, Andrea Antinori et al. · Antiviral Therapy · 2002 · 159 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

Dimitrios Paraskevis, Oliver G. Pybus, Gkikas Magiorkinis et al. · Retrovirology · 2009 · 123 citations · Full text

Life Sciences, Biology, Infectious Diseases +17

Carbohydrate-binding Agents Cause Deletions of Highly Conserved Glycosylation Sites in HIV GP120

Jan Balzarini, Kristel Van Laethem, Sigrid Hatse et al. · Journal of Biological Chemistry · 2005 · 123 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17